A 24-Week, Double-Blind, Placebo-Controlled, Randomized Human Application Study to Evaluate the Efficacy and Safety of CosmeRNA-ARI Anti Hair Loss Tonic in Adults With Androgenetic Alopecia (NCTNCT07898566) - Patient Guide & Enrollment Help